Don’t foresee any disruptions due to Covid-19: Vasant Narasimhan, CEO, Novartis
Posted by
www.biotecnika.org
Novartis is one of the oldest pharma MNCs known for anti-cancer and
anti-diabetic drugs. Despite the patent expiry for its popular
anti-diabetic drug Galvus, Narasimhan is upbeat about Novartis' India
prospects.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dont-foresee-any-disruptions-due-to-covid-19-vasant-narasimhan-ceo-novartis/articleshow/74183607.cms
Subscribe to:
Post Comments (Atom)
Post a Comment